These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5707796)

  • 1. Effects of ethyl-p-chlorophenoxyisobutyrate, clofibrate, on the plasma and red blood cell free fatty acids of the rat.
    Cenedella RJ; Jarrell JJ; Saxe LH
    J Atheroscler Res; 1968; 8(6):903-11. PubMed ID: 5707796
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the mode of action of clofibrate: effects on hormone-induced changes in plasma free fatty acids, cholesterol, phospholipids and total esterified fatty acids in rats and dogs.
    Barrett AM; Thorp JM
    Br J Pharmacol Chemother; 1968 Feb; 32(2):381-91. PubMed ID: 4296427
    [No Abstract]   [Full Text] [Related]  

  • 3. A COMPARISON OF THE EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE AND NICOTINIC ACID ON PLASMA FREE FATTY ACIDS.
    DUNCAN CH; BEST MM; ROBERTSON GL
    Lancet; 1965 Jan; 1(7378):191-3. PubMed ID: 14238047
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of ethyl chlorophenoxyisobutyrate (CPIB) on the uptake of triglyceride fatty acids, activity of lipoprotein lipase and lipogenesis from glucose in fat tissue of rats.
    Nestel PJ; Austin W
    J Atheroscler Res; 1968; 8(5):827-33. PubMed ID: 5688379
    [No Abstract]   [Full Text] [Related]  

  • 5. Clofibrate effect on catecholamine-induced metabolic changes in humans.
    Hunninghake DB; Azarnoff DL
    Metabolism; 1968 Jul; 17(7):588-95. PubMed ID: 4872374
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of ethyl p-chlorophenoxyisobutyrate on rat adipose lipoprotein lipase activity.
    Tolman EL; Tepperman HM; Tepperman J
    Am J Physiol; 1970 May; 218(5):1313-8. PubMed ID: 4314568
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of CPIB ester on plasma free fatty acid levels in man.
    Rifkind BM
    Metabolism; 1966 Aug; 15(8):673-5. PubMed ID: 5341113
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of ethyl alpha-p. chlorophenoxyisobutyrate on ethanol-induced hepatic steatosis in the rat.
    Brown DF
    Metabolism; 1966 Oct; 15(10):868-73. PubMed ID: 5923523
    [No Abstract]   [Full Text] [Related]  

  • 9. Decrease of ethanol-induced fatty liver by ethyl alpha-p-chlorophenoxyisobutyrate.
    Spritz N; Lieber CS
    Proc Soc Exp Biol Med; 1966 Jan; 121(1):147-9. PubMed ID: 5902917
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum phospholipid alterations and their control by chlorophenoxyisobutyrate and betabenzalbutyrate in puromycin aminonucleoside induced nephrotic syndrome in the rat.
    Gallt C; Edwards KD; Paoletti R
    Life Sci II; 1970 May; 9(9):523-34. PubMed ID: 5452796
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum lipid responses to ethyl-p-chlorophenoxyisobutyrate with different dietary fats.
    Kokatnur MG; Malcom GT; Martinez RD
    Metabolism; 1969 Jan; 18(1):73-80. PubMed ID: 5764810
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacologic study of a hypocholesteremic agent (MG. 46)].
    Nordmann J; Loiseau G; Berthe G; Lohier P; Truchaud M
    Therapie; 1972; 27(2):339-58. PubMed ID: 4673514
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
    Tomita T; Takeshita R; Nagakura T; Hayashi E
    Jpn J Pharmacol; 1973 Jun; 23(3):281-7. PubMed ID: 4541943
    [No Abstract]   [Full Text] [Related]  

  • 14. Degradation kinetics of liver catalase in rats treated with ethyl-alpha-p-chlorophenoxyisobutyrate.
    Chiga M; Reddy J; Svoboda D
    Lab Invest; 1971 Jul; 25(1):49-52. PubMed ID: 5555696
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of short-term use of clofibrate on the blood level of cholesterol, beta lipoproteins and free fatty acids].
    Modzelewski A; Zaczek-Modzelewska T
    Wiad Lek; 1970 Nov; 23(21):1937-9. PubMed ID: 5485649
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of ethylchlorophenoxyisobutyrate on weight, plasma volume, total body-water, and free fatty acids.
    Macmillan DC; Oliver MF; Simpson JD; Tothill P
    Lancet; 1965 Nov; 2(7419):924-6. PubMed ID: 4165275
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of chlorophenoxyisobutyric acid (CPIB) on adrenaline-induced lipolysis in vitro.
    Blackard WG; Kokatnur MG
    J Atheroscler Res; 1968; 8(1):189-91. PubMed ID: 5642102
    [No Abstract]   [Full Text] [Related]  

  • 18. Clofibrate inhibits lipid synthesis and ACTH-stimulated steroidogenesis by rat adrenal tissue.
    Saffran J; Saffran M; Salhanick HA
    Endocrinology; 1970 Mar; 86(3):652-5. PubMed ID: 4312114
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of ethyl chlorophenoxyisobutyrate on postprandial lipemia].
    Beaumont JL; Menard J; Beaumont V
    Rev Atheroscler (Paris); 1966; 8(1):21-6. PubMed ID: 5960551
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of chlorophenoxyisobutyrate on plasma composition of cholesteryl esters and on levels of neutral lipids.
    Hagopian M; Robinson RW
    J Atheroscler Res; 1968; 8(1):21-7. PubMed ID: 5642104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.